{
    "clinical_study": {
        "@rank": "121237", 
        "brief_summary": {
            "textblock": "Blood contains different kinds of cells, white blood cells, red blood cells, and platelets.\n      In order to treat certain diseases, specific cell types can be removed from blood and\n      transplanted into patients.  The process of removing white blood cells for the treatment of\n      leukemia is called apheresis.\n\n      This study will make available blood cell collections from volunteers genetically matched to\n      various degrees with recipients in order to test and, if necessary, refine the process of\n      removing white blood cell T-lymphocytes."
        }, 
        "brief_title": "Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease", 
        "condition": [
            "Graft vs Host Disease", 
            "Hematologic Neoplasm"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Graft vs Host Disease", 
                "Hematologic Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "This protocol has been written to make available apheresis collections from volunteers\n      matched to various degrees with recipients in order to test and, if necessary refine, the\n      selective immunodepletion procedure prior to introducing it in a clinical trial."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "-  INCLUSION CRITERIA:\n\n        Family members of patients admitted to NHLBI allogeneic BMT protocols.\n\n        Ages 18 and older and less than age 65.\n\n        Parent of patient (obligate haplotype match) OR HLA 3/6, 4/6, 5/6, or 6/6 match with\n        patient.\n\n        Research apheresis available from patient.\n\n        EXCLUSION CRITERIA:\n\n        Pregnancy or lactation.\n\n        HLA type unknown.\n\n        More than one haplotype mismatch with patient.\n\n        History of any immunosuppressive disease.\n\n        History of chronic viral antigenic stimulus.\n\n        Venous access inadequate."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 3, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00001872", 
            "org_study_id": "990037", 
            "secondary_id": "99-H-0037"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Volunteer", 
            "Leukocyte Donors", 
            "Family Members", 
            "Leukocyte Collection", 
            "No Reimbursement"
        ], 
        "lastchanged_date": "March 14, 2014", 
        "link": {
            "description": "NIH Clinical Center Detailed Web Page", 
            "url": "http://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_1999-H-0037.html"
        }, 
        "location": {
            "contact": {
                "email": "prpl@mail.cc.nih.gov", 
                "last_name": "For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL)", 
                "phone": "800-411-1222", 
                "phone_ext": "TTY8664111010"
            }, 
            "facility": {
                "address": {
                    "city": "Bethesda", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "20892"
                }, 
                "name": "National Institutes of Health Clinical Center, 9000 Rockville Pike"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Apheresis of Family Members of Patients Undergoing Allogeneic Bone Marrow Transplantation. A Pre-Clinical Study of Selective Depletion of Donor Lymphocytes to Prevent Acute Graft-Versus-Host Disease", 
        "overall_contact": {
            "email": "ekozanas@nih.gov", 
            "last_name": "Eleftheria Koklanaris, R.N.", 
            "phone": "(301) 594-4709"
        }, 
        "overall_contact_backup": {
            "email": "barrettj@nhlbi.nih.gov", 
            "last_name": "A. John Barrett, M.D.", 
            "phone": "(301) 402-4170"
        }, 
        "overall_official": {
            "affiliation": "National Heart, Lung, and Blood Institute (NHLBI)", 
            "last_name": "A. John Barrett, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "reference": [
            {
                "PMID": "7858526", 
                "citation": "Datta AR, Barrett AJ, Jiang YZ, Guimaraes A, Mavroudis DA, van Rhee F, Gordon AA, Madrigal A. Distinct T cell populations distinguish chronic myeloid leukaemia cells from lymphocytes in the same individual: a model for separating GVHD from GVL reactions. Bone Marrow Transplant. 1994 Oct;14(4):517-24."
            }, 
            {
                "PMID": "8733700", 
                "citation": "Mavroudis DA, Jiang YZ, Hensel N, Lewalle P, Couriel D, Kreitman RJ, Pastan I, Barrett AJ. Specific depletion of alloreactivity against haplotype mismatched related individuals by a recombinant immunotoxin: a new approach to graft-versus-host disease prophylaxis in haploidentical bone marrow transplantation. Bone Marrow Transplant. 1996 May;17(5):793-9."
            }, 
            {
                "PMID": "9633903", 
                "citation": "Mavroudis DA, Dermime S, Molldrem J, Jiang YZ, Raptis A, van Rhee F, Hensel N, Fellowes V, Eliopoulos G, Barrett AJ. Specific depletion of alloreactive T cells in HLA-identical siblings: a method for separating graft-versus-host and graft-versus-leukaemia reactions. Br J Haematol. 1998 Jun;101(3):565-70."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00001872"
        }, 
        "source": "National Institutes of Health Clinical Center (CC)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Heart, Lung, and Blood Institute (NHLBI)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "February 1999", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "June 2013"
    }, 
    "geocoordinates": {
        "National Institutes of Health Clinical Center, 9000 Rockville Pike": "38.985 -77.095"
    }
}